A seroepidemiologic study of a measles outbreak, Yamagata Prefecture, Japan, 2017: The estimation of spreaders using serological assays in a measles elimination setting

In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we...

Full description

Saved in:
Bibliographic Details
Published inJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 28; no. 7; pp. 1018 - 1022
Main Authors Seto, Junji, Aoki, Yoko, Tanaka, Shizuka, Komabayashi, Kenichi, Ikeda, Tatsuya, Mizuta, Katsumi
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.07.2022
Subjects
Online AccessGet full text
ISSN1341-321X
1437-7780
1437-7780
DOI10.1016/j.jiac.2022.03.025

Cover

Loading…
Abstract In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we performed a seroepidemiologic study of a measles outbreak in Yamagata Prefecture, Japan, in 2017. We tested plaque reduction neutralization (PRN), IgG avidity, and gelatin particle agglutination (PA) assays in 31 patients with measles, subdivided into two super-spreaders, three spreaders, and 26 non-spreaders. Simultaneously, these results were compared with the cycle threshold (Ct) of a semi-quantitative real-time reverse transcription PCR for the measles virus from throat swab specimens. In the PRN assay, one super-spreader and two spreaders lacked protective antibodies. The IgG avidity assay showed that two super-spreaders and one spreader had low avidity. The PA assay indicated that two super-spreaders and two spreaders lacked protective antibodies. Comparison of the results of the three serological assays and Ct revealed that patients whose antibody titers were judged as low in the IgG avidity and PA assays showed low Ct (i.e., high viral load), whereas non-spreaders tended to show low viral load. Our preliminary seroepidemiologic analysis of a population of 31 patients with measles suggests that PA and IgG avidity assays may be used for the identification of super-spreader/spreader candidates. However, further investigations are necessary to validate the robustness of these serological assays in detecting contagious measles cases.
AbstractList In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we performed a seroepidemiologic study of a measles outbreak in Yamagata Prefecture, Japan, in 2017.INTRODUCTIONIn regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we performed a seroepidemiologic study of a measles outbreak in Yamagata Prefecture, Japan, in 2017.We tested plaque reduction neutralization (PRN), IgG avidity, and gelatin particle agglutination (PA) assays in 31 patients with measles, subdivided into two super-spreaders, three spreaders, and 26 non-spreaders. Simultaneously, these results were compared with the cycle threshold (Ct) of a semi-quantitative real-time reverse transcription PCR for the measles virus from throat swab specimens.METHODSWe tested plaque reduction neutralization (PRN), IgG avidity, and gelatin particle agglutination (PA) assays in 31 patients with measles, subdivided into two super-spreaders, three spreaders, and 26 non-spreaders. Simultaneously, these results were compared with the cycle threshold (Ct) of a semi-quantitative real-time reverse transcription PCR for the measles virus from throat swab specimens.In the PRN assay, one super-spreader and two spreaders lacked protective antibodies. The IgG avidity assay showed that two super-spreaders and one spreader had low avidity. The PA assay indicated that two super-spreaders and two spreaders lacked protective antibodies. Comparison of the results of the three serological assays and Ct revealed that patients whose antibody titers were judged as low in the IgG avidity and PA assays showed low Ct (i.e., high viral load), whereas non-spreaders tended to show low viral load.RESULTSIn the PRN assay, one super-spreader and two spreaders lacked protective antibodies. The IgG avidity assay showed that two super-spreaders and one spreader had low avidity. The PA assay indicated that two super-spreaders and two spreaders lacked protective antibodies. Comparison of the results of the three serological assays and Ct revealed that patients whose antibody titers were judged as low in the IgG avidity and PA assays showed low Ct (i.e., high viral load), whereas non-spreaders tended to show low viral load.Our preliminary seroepidemiologic analysis of a population of 31 patients with measles suggests that PA and IgG avidity assays may be used for the identification of super-spreader/spreader candidates. However, further investigations are necessary to validate the robustness of these serological assays in detecting contagious measles cases.CONCLUSIONSOur preliminary seroepidemiologic analysis of a population of 31 patients with measles suggests that PA and IgG avidity assays may be used for the identification of super-spreader/spreader candidates. However, further investigations are necessary to validate the robustness of these serological assays in detecting contagious measles cases.
In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we performed a seroepidemiologic study of a measles outbreak in Yamagata Prefecture, Japan, in 2017. We tested plaque reduction neutralization (PRN), IgG avidity, and gelatin particle agglutination (PA) assays in 31 patients with measles, subdivided into two super-spreaders, three spreaders, and 26 non-spreaders. Simultaneously, these results were compared with the cycle threshold (Ct) of a semi-quantitative real-time reverse transcription PCR for the measles virus from throat swab specimens. In the PRN assay, one super-spreader and two spreaders lacked protective antibodies. The IgG avidity assay showed that two super-spreaders and one spreader had low avidity. The PA assay indicated that two super-spreaders and two spreaders lacked protective antibodies. Comparison of the results of the three serological assays and Ct revealed that patients whose antibody titers were judged as low in the IgG avidity and PA assays showed low Ct (i.e., high viral load), whereas non-spreaders tended to show low viral load. Our preliminary seroepidemiologic analysis of a population of 31 patients with measles suggests that PA and IgG avidity assays may be used for the identification of super-spreader/spreader candidates. However, further investigations are necessary to validate the robustness of these serological assays in detecting contagious measles cases.
Author Ikeda, Tatsuya
Seto, Junji
Aoki, Yoko
Komabayashi, Kenichi
Mizuta, Katsumi
Tanaka, Shizuka
Author_xml – sequence: 1
  givenname: Junji
  orcidid: 0000-0003-2227-5315
  surname: Seto
  fullname: Seto, Junji
  email: setoj@pref.yamagata.jp
– sequence: 2
  givenname: Yoko
  surname: Aoki
  fullname: Aoki, Yoko
– sequence: 3
  givenname: Shizuka
  surname: Tanaka
  fullname: Tanaka, Shizuka
– sequence: 4
  givenname: Kenichi
  orcidid: 0000-0003-0900-8845
  surname: Komabayashi
  fullname: Komabayashi, Kenichi
– sequence: 5
  givenname: Tatsuya
  surname: Ikeda
  fullname: Ikeda, Tatsuya
– sequence: 6
  givenname: Katsumi
  orcidid: 0000-0001-8965-9925
  surname: Mizuta
  fullname: Mizuta, Katsumi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35396155$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URH_gBVggL1lMgu3ETlKxqaryp0qwKBKsrBvnZvA0iQfbQZo36mPizLQS6qKs7MX5ztE955QcTW5CQl5zlnPG1btNvrFgcsGEyFmRMyGfkRNeFlVWVTU7Sv-i5Fkh-I9jchrChjFeybp-QY4LWTSKS3lC7i5oQO9wazscrRvc2hoa4tztqOsp0BEhDBiom2PrEW5X9CeMsIYI9JvHHk2cPa7oF9jCtKIiJZzTm19IMUQ7QrRuWnzCNrEd-kDnYKf1PnIfBQOFEGAXqJ3-ScPBjnY64AFjTMxL8ryHIeCr-_eMfP9wdXP5Kbv--vHz5cV1Zsqmilnb8162fWv6HhQD1bGuFEoCZ6wxRrV1YapWVlJKbEsBLa-h64RqoaoaBY0ozsjbg-_Wu99zOkOPNhgcBpjQzUELVdZ1o4RQSfrmXjq3I3Z669PJfqcf2k2C-iAw3oWQ6tLGxv1V0YMdNGd6GVJv9DKkXobUrNBpyISKR-iD-5PQ-wOEqaA_Fr0OxuJksLM-LaU7Z5_Gzx_hZrDTMtIt7v4H_wVFqM1f
CitedBy_id crossref_primary_10_1265_jjh_24002
crossref_primary_10_3390_v15010171
Cites_doi 10.2807/1560-7917.ES.2018.23.24.1800239
10.1017/S095026881800211X
10.1128/CVI.00268-16
10.1002/jmv.26733
10.3389/fmicb.2019.01470
10.1128/CVI.00406-12
10.1016/j.vaccine.2019.11.075
10.1093/infdis/162.5.1036
10.7883/yoken.JJID.2018.083
10.1007/s007050050215
ContentType Journal Article
Copyright 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases
Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases
– notice: Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jiac.2022.03.025
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1437-7780
EndPage 1022
ExternalDocumentID 35396155
10_1016_j_jiac_2022_03_025
S1341321X22001040
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
--M
-Y2
-~C
.1-
.55
.86
.FO
.~1
0R~
0VY
1N0
1P~
1SB
1~.
2.D
28-
29K
2JY
2P1
2VQ
2~H
30V
4.4
408
409
40D
457
4G.
53G
5GY
5QI
5VS
67Z
6NX
7-5
8P~
8TC
8UJ
95.
95~
AAAJQ
AAEDT
AAEDW
AAIAL
AAIKJ
AAKOC
AALRI
AANXM
AAOAW
AAQFI
AARHV
AATTM
AAXKI
AAXUO
AAYWO
AAYZH
ABFSG
ABJNI
ABMAC
ABMNI
ABMZM
ABQSL
ABXDB
ACDAQ
ACGFS
ACIEU
ACOMO
ACRLP
ACSTC
ACVFH
ADBBV
ADCNI
ADEZE
ADHKG
ADIMF
ADKPE
ADQRH
ADRFC
ADVLN
AEBSH
AEFIE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEZWR
AFBBN
AFEXP
AFHIU
AFLOW
AFPUW
AFRHN
AFTJW
AFWTZ
AFXIZ
AGCQF
AGGDS
AGHFR
AGJBK
AGQPQ
AGUBO
AHBYD
AHKAY
AHSBF
AHWEU
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AIXLP
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMRAJ
ANKPU
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BA0
BBWZM
BGNMA
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
CSCUP
D-I
DL5
EBS
EFJIC
EFKBS
EJD
EMOBN
EN4
F5P
FDB
FEDTE
FIRID
FYGXN
GBLVA
GQ8
GXS
H13
HF~
HG5
HG6
HMJXF
HVGLF
HZ~
I09
IHE
IXC
IXE
IZIGR
IZQ
I~X
KDC
KOM
KOW
KPH
LAS
M41
M4Y
MA-
MO0
N2Q
N9A
NB0
NDZJH
NU0
O9-
O93
O9G
O9I
OAM
OAUVE
OC~
P-8
P-9
P19
P2P
P9S
PC.
PT5
QOK
QOS
R4E
R89
R9I
RNI
ROL
RPX
RRX
RSV
RZK
S1Z
S26
S27
S28
S37
S3B
SDE
SDH
SDM
SMD
SOJ
SPCBC
SSH
SSZ
SV3
T13
T16
T5K
TSK
TSV
TT1
TUC
U2A
VC2
WJK
WK8
X7M
Z45
Z5R
~A9
~EX
~G-
-5E
-5G
-BR
0SF
AACTN
AAIAV
ABLVK
ABTEG
ABYKQ
ADINQ
AFKWA
AFNRJ
AHPSJ
AJBFU
AJOXV
AMFUW
EFLBG
GQ6
NCXOZ
RIG
SSI
SZN
Z7U
Z82
Z87
Z8O
Z8V
Z91
AAYXX
AFCTW
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c497t-bf1f5bfbcffa60a6d0d4265a1009cc6b83c7b57555eb42ab18add26ba7796a923
IEDL.DBID .~1
ISSN 1341-321X
1437-7780
IngestDate Mon Jul 21 10:47:17 EDT 2025
Thu Apr 03 07:00:11 EDT 2025
Tue Jul 01 02:23:38 EDT 2025
Thu Apr 24 23:03:58 EDT 2025
Fri Feb 23 02:39:46 EST 2024
Tue Aug 26 18:42:30 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Gelatin particle agglutination
Vaccine
Plaque reduction neutralization
IgG avidity
Super-spreader
Language English
License Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c497t-bf1f5bfbcffa60a6d0d4265a1009cc6b83c7b57555eb42ab18add26ba7796a923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2227-5315
0000-0003-0900-8845
0000-0001-8965-9925
PMID 35396155
PQID 2648896226
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_2648896226
pubmed_primary_35396155
crossref_citationtrail_10_1016_j_jiac_2022_03_025
crossref_primary_10_1016_j_jiac_2022_03_025
elsevier_sciencedirect_doi_10_1016_j_jiac_2022_03_025
elsevier_clinicalkey_doi_10_1016_j_jiac_2022_03_025
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2022
2022-07-00
2022-Jul
20220701
PublicationDateYYYYMMDD 2022-07-01
PublicationDate_xml – month: 07
  year: 2022
  text: July 2022
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
PublicationTitleAlternate J Infect Chemother
PublicationYear 2022
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Mizumoto, Kobayashi, Chowell (bib5) 2018; 23
Mercader, Garcia, Bellini (bib9) 2012; 19
Chen, Markowitz, Albrecht, Stewart, Mofenson, Preblud (bib14) 1990; 162
Komabayashi, Seto, Tanaka, Suzuki, Ikeda, Onuki (bib4) 2018; 71
Seki, Miyoshi, Ikeda, Nishijima, Saikusa, Itamochi (bib3) 2019; 10
Sato, Miyamura, Sakae, Kobune, Inouye, Fujino (bib7) 1997; 142
Kurata, Yamamoto, Nishimura, Yumisashi, Motomura, Kinoshita (bib15) 2021; 93
World Health Organization (bib2) 2012
(bib12) 2017
(bib10) 2020
Moss, Griffin (bib1) 2014
Sowers, Rota, Hickman, Mercader, Redd, McNall (bib8) 2016; 23
(bib11) 2021
Kurata, Kanbayashi, Egawa, Kinoshita, Yoshida, Miyazono (bib13) 2020; 38
Seto, Ikeda, Tanaka, Komabayashi, Matoba, Suzuki (bib6) 2018; 146
Moss (10.1016/j.jiac.2022.03.025_bib1) 2014
(10.1016/j.jiac.2022.03.025_bib10) 2020
Mercader (10.1016/j.jiac.2022.03.025_bib9) 2012; 19
(10.1016/j.jiac.2022.03.025_bib11) 2021
(10.1016/j.jiac.2022.03.025_bib12) 2017
Kurata (10.1016/j.jiac.2022.03.025_bib13) 2020; 38
Chen (10.1016/j.jiac.2022.03.025_bib14) 1990; 162
Komabayashi (10.1016/j.jiac.2022.03.025_bib4) 2018; 71
Seki (10.1016/j.jiac.2022.03.025_bib3) 2019; 10
World Health Organization (10.1016/j.jiac.2022.03.025_bib2) 2012
Kurata (10.1016/j.jiac.2022.03.025_bib15) 2021; 93
Sato (10.1016/j.jiac.2022.03.025_bib7) 1997; 142
Mizumoto (10.1016/j.jiac.2022.03.025_bib5) 2018; 23
Seto (10.1016/j.jiac.2022.03.025_bib6) 2018; 146
Sowers (10.1016/j.jiac.2022.03.025_bib8) 2016; 23
References_xml – volume: 142
  start-page: 1971
  year: 1997
  end-page: 1977
  ident: bib7
  article-title: Development of a gelatin particle agglutination reagent for measles antibody assay
  publication-title: Arch Virol
– year: 2017
  ident: bib12
  article-title: Laboratory manuals for pathogen detection
– volume: 38
  start-page: 1467
  year: 2020
  end-page: 1475
  ident: bib13
  article-title: A measles outbreak from an index case with immunologically confirmed secondary vaccine failure
  publication-title: Vaccine
– year: 2014
  ident: bib1
  article-title: Paramyxoviruses: measles
  publication-title: Viral infections of humans, epidemilogy and control
– volume: 23
  start-page: 707
  year: 2016
  end-page: 716
  ident: bib8
  article-title: High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases
  publication-title: Clin Vaccine Immunol
– volume: 71
  start-page: 413
  year: 2018
  end-page: 418
  ident: bib4
  article-title: The largest measles outbreak, including 38 modified measles and 22 typical measles cases in its elimination era in Yamagata, Japan, 2017
  publication-title: Jpn J Infect Dis
– volume: 146
  start-page: 1707
  year: 2018
  end-page: 1713
  ident: bib6
  article-title: Detection of modified measles and super-spreader using a real-time reverse transcription PCR in the largest measles outbreak, Yamagata, Japan, 2017 in its elimination era
  publication-title: Epidemiol Infect
– volume: 93
  start-page: 3446
  year: 2021
  end-page: 3454
  ident: bib15
  article-title: A measles outbreak in Kansai International Airport, Japan, 2016: analysis of the quantitative difference and infectivity of measles virus between patients who are immunologically naive versus those with secondary vaccine failure
  publication-title: J Med Virol
– volume: 10
  start-page: 1470
  year: 2019
  ident: bib3
  article-title: Nationwide molecular epidemiology of measles virus in Japan between 2008 and 2017
  publication-title: Front Microbiol
– volume: 162
  start-page: 1036
  year: 1990
  end-page: 1042
  ident: bib14
  article-title: Measles antibody: reevaluation of protective titers
  publication-title: J Infect Dis
– year: 2021
  ident: bib11
  article-title: Annual Report 2019, National epidemiological surveillance, of vaccine-preventable diseases: measles
– year: 2012
  ident: bib2
  article-title: Global measles and rubella strategic plan 2012-2020
– volume: 23
  start-page: 1800239
  year: 2018
  ident: bib5
  article-title: Transmission potential of modified measles during an outbreak, Japan, March‒May 2018
  publication-title: Euro Surveill
– year: 2020
  ident: bib10
  article-title: Vaccine guidelines for health care providers
– volume: 19
  start-page: 1810
  year: 2012
  end-page: 1817
  ident: bib9
  article-title: Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings
  publication-title: Clin Vaccine Immunol
– volume: 23
  start-page: 1800239
  year: 2018
  ident: 10.1016/j.jiac.2022.03.025_bib5
  article-title: Transmission potential of modified measles during an outbreak, Japan, March‒May 2018
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.2018.23.24.1800239
– volume: 146
  start-page: 1707
  year: 2018
  ident: 10.1016/j.jiac.2022.03.025_bib6
  article-title: Detection of modified measles and super-spreader using a real-time reverse transcription PCR in the largest measles outbreak, Yamagata, Japan, 2017 in its elimination era
  publication-title: Epidemiol Infect
  doi: 10.1017/S095026881800211X
– year: 2014
  ident: 10.1016/j.jiac.2022.03.025_bib1
  article-title: Paramyxoviruses: measles
– volume: 23
  start-page: 707
  year: 2016
  ident: 10.1016/j.jiac.2022.03.025_bib8
  article-title: High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00268-16
– year: 2021
  ident: 10.1016/j.jiac.2022.03.025_bib11
– volume: 93
  start-page: 3446
  year: 2021
  ident: 10.1016/j.jiac.2022.03.025_bib15
  article-title: A measles outbreak in Kansai International Airport, Japan, 2016: analysis of the quantitative difference and infectivity of measles virus between patients who are immunologically naive versus those with secondary vaccine failure
  publication-title: J Med Virol
  doi: 10.1002/jmv.26733
– volume: 10
  start-page: 1470
  year: 2019
  ident: 10.1016/j.jiac.2022.03.025_bib3
  article-title: Nationwide molecular epidemiology of measles virus in Japan between 2008 and 2017
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2019.01470
– year: 2020
  ident: 10.1016/j.jiac.2022.03.025_bib10
– year: 2017
  ident: 10.1016/j.jiac.2022.03.025_bib12
– volume: 19
  start-page: 1810
  year: 2012
  ident: 10.1016/j.jiac.2022.03.025_bib9
  article-title: Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00406-12
– volume: 38
  start-page: 1467
  year: 2020
  ident: 10.1016/j.jiac.2022.03.025_bib13
  article-title: A measles outbreak from an index case with immunologically confirmed secondary vaccine failure
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2019.11.075
– volume: 162
  start-page: 1036
  year: 1990
  ident: 10.1016/j.jiac.2022.03.025_bib14
  article-title: Measles antibody: reevaluation of protective titers
  publication-title: J Infect Dis
  doi: 10.1093/infdis/162.5.1036
– volume: 71
  start-page: 413
  year: 2018
  ident: 10.1016/j.jiac.2022.03.025_bib4
  article-title: The largest measles outbreak, including 38 modified measles and 22 typical measles cases in its elimination era in Yamagata, Japan, 2017
  publication-title: Jpn J Infect Dis
  doi: 10.7883/yoken.JJID.2018.083
– volume: 142
  start-page: 1971
  year: 1997
  ident: 10.1016/j.jiac.2022.03.025_bib7
  article-title: Development of a gelatin particle agglutination reagent for measles antibody assay
  publication-title: Arch Virol
  doi: 10.1007/s007050050215
– year: 2012
  ident: 10.1016/j.jiac.2022.03.025_bib2
SSID ssj0017588
Score 2.3032506
Snippet In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1018
SubjectTerms Antibodies, Viral
Disease Outbreaks
Gelatin particle agglutination
Humans
IgG avidity
Immunoglobulin G
Japan - epidemiology
Measles - diagnosis
Measles - epidemiology
Measles - prevention & control
Measles virus - genetics
Plaque reduction neutralization
Seroepidemiologic Studies
Super-spreader
Vaccine
Title A seroepidemiologic study of a measles outbreak, Yamagata Prefecture, Japan, 2017: The estimation of spreaders using serological assays in a measles elimination setting
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1341321X22001040
https://dx.doi.org/10.1016/j.jiac.2022.03.025
https://www.ncbi.nlm.nih.gov/pubmed/35396155
https://www.proquest.com/docview/2648896226
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELam8cIL4jflx2QktBcS2jixk_BWTUxliKkSm1SeLNuzp4wuqZb0oS_8PfyZ3NlJCxIMicdWvjrqne--yN99R8ibTBkmbGHirOA2zhLm4sIIOHhaYaejY9aTxz-fitl5drLgiz1yNPTCIK2yz_0hp_ts3X8z7v_N8aqqxl9QiixlyYIxLzKD7-1ZlmOUv_u-pXlAdfSzJ3FxjKv7xpnA8bqqFMoYMuaFTnFc9p-L09_Apy9Cx_fJvR490ml4wAdkz9YPyeE8yE9vInq266ZqI3pI5zth6s0j8mNKIeAauxsKWxnq9WVp46ii11a1S9vSZt3Bi7L6FtGv6lpdqk7ROY4j8bcNET2B-lpHFGp6_h53pCjUETog8Xfa1U2gR1Pk1F_6LfsESwGpq01Lq_qX3ezSDxbz5q31NOzH5Pz4w9nRLO4nNcQmK_Mu1i5xXDttnFNiosTF5AIqP1cJIDhjhC5Sk2sAhpxbnTGlkwLSKhNa5XkpFGDMJ2S_bmr7jFBj0xxnZqW8ALCkXVEmzgjOC2OgyBo-IsngIml6GXOcprGUA1_tSqJbJbpVTlIJbh2Rt1ubVRDxuHV1OnheDu2pkFAl1JhbrfjW6rcA_qfd6yG4JJxsvK5RtW3WrUTuYVEKwMcj8jRE3fbpU56WeKP8_D93fUHu4qfAO35J9rubtX0F6KrTB_74HJA704-fZqc_AVCNJZw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBZL9tBeSt9NnyqUvTQmsWzJdm9h6ZJ9hUCzkJ6EpJUW72btsHYO-Uf9mZ2R7aSFdgu92h7LeKSZT-ibbwj5FCvDhE1NEKfcBnHIXJAaAQtPK6x0dMx68vj5VEwu4pMFX-yRw64WBmmVbexvYrqP1u2VYfs3h6s8H35DKbKIhQvGvMgM7Nv3UZ2K98j--Ph0Mt0eJgAk9hVx8HyABm3tTEPzus4VKhky5rVOsWP2n_PT3_Cnz0NHj8mjFkDScfONT8ieLZ6Sg1mjQL0Z0PmuoKoa0AM622lTb56RH2MKc660u76wuaFeYpaWjip6a1W1tBUt1zXsldXNgH5Xt-pK1YrOsCOJP3AY0BNIscWAQlpPvuCIFLU6miJIfE-1umsY0hRp9Vd-yDbGUgDralPRvPhlNLv0vcW8eWU9E_s5uTj6Oj-cBG2zhsDEWVIH2oWOa6eNc0qMlLgcXULy5yoEEGeM0GlkEg3YkHOrY6Z0mEJkZUKrJMmEApj5gvSKsrCvCDU2SrBtVsRTwEvapVnojOA8NQbyrOF9EnYukqZVMseGGkvZUdauJbpVolvlKJLg1j75vLVZNToe9z4ddZ6XXYUqxFQJaeZeK761-m0O_9PuYze5JCxuPLFRhS3XlUT6YZoJgMh98rKZdduvj3iU4aHy6_8c9QN5MJmfn8mz4-npG_IQ7zQ05LekV9-t7TsAW7V-3y6mn0WNKE0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+seroepidemiologic+study+of+a+measles+outbreak%2C+Yamagata+Prefecture%2C+Japan%2C+2017%3A+The+estimation+of+spreaders+using+serological+assays+in+a+measles+elimination+setting&rft.jtitle=Journal+of+infection+and+chemotherapy+%3A+official+journal+of+the+Japan+Society+of+Chemotherapy&rft.au=Seto%2C+Junji&rft.au=Aoki%2C+Yoko&rft.au=Tanaka%2C+Shizuka&rft.au=Komabayashi%2C+Kenichi&rft.date=2022-07-01&rft.pub=Elsevier+Ltd&rft.issn=1341-321X&rft.volume=28&rft.issue=7&rft.spage=1018&rft.epage=1022&rft_id=info:doi/10.1016%2Fj.jiac.2022.03.025&rft.externalDocID=S1341321X22001040
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-321X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-321X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-321X&client=summon